Javier Cid-Ruzafa
University of Leicester
15 Papers
20 Citations
Javier Cid-Ruzafa is an academic researcher from University of Leicester. The author has contributed to research in topics: Medicine & Type 2 diabetes. The author has an hindex of 5, co-authored 15 publications.
Chat about Author
Papers
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
Mikhail Kosiborod,Marília B. Gomes,Antonio Nicolucci,Stuart J. Pocock,Wolfgang Rathmann,Marina Vladimirovna Shestakova,Hirotaka Watada,Iichiro Shimomura,Hungta Chen,Javier Cid-Ruzafa,Peter Fenici,Niklas Hammar,Niklas Hammar,Filip Surmont,Fengming Tang,Kamlesh Khunti,Discover investigators +16 more
TL;DR: The global burden of microvascular and macrovascular complications is substantial in patients with type 2 diabetes who are relatively early in the disease process, and these findings highlight an opportunity for aggressive early risk factor modification, particularly in regions with a high prevalence of complications.
232
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study.
Marília B. Gomes,Wolfgang Rathmann,Bernard Charbonnel,Kamlesh Khunti,Mikhail Kosiborod,Antonio Nicolucci,Stuart J. Pocock,Marina Vladimirovna Shestakova,Iichiro Shimomura,Fengming Tang,Hirotaka Watada,Hungta Chen,Javier Cid-Ruzafa,Peter Fenici,Niklas Hammar,Filip Surmont,Linong Ji,Discover investigators +17 more
TL;DR: Significant global variation in the treatment of type 2 diabetes mellitus is demonstrated, and a need for more aggressive risk factor control is demonstrated.
84
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Kamlesh Khunti,Thomas Godec,Jesús Medina,Laura Garcia‐Alvarez,Josh Hiller,Marília B. Gomes,Javier Cid-Ruzafa,Bernard Charbonnel,Peter Fenici,Niklas Hammar,Niklas Hammar,Kiyoshi Hashigami,Mikhail Kosiborod,Antonio Nicolucci,Marina Vladimirovna Shestakova,Linong Ji,Stuart J. Pocock +16 more
TL;DR: Determinants of change in glycated haemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM) at 6 months after initiating uninterrupted second‐line glucose‐lowering therapies are investigated.
47
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Barbara Band,Suzanne V. Arnold,Kamlesh Khunti,Fengming Tang,Hungta Chen,Javier Cid-Ruzafa,Andrew Cooper,Peter Fenici,Marília B. Gomes,Niklas Hammar,Linong Ji,Gabriela Luporini Saraiva,Jesús Medina,Antonio Nicolucci,Larisa Ramirez,Wolfgang Rathmann,Marina Vladimirovna Shestakova,Iichiro Shimomura,Filip Surmont,Jiten Vora,Hirotaka Watada,Mikhail Kosiborod,Mikhail Kosiborod +22 more
TL;DR: In this paper, the authors examined the incidence of vascular complications over 3 years of follow-up in the DISCOVER study, a global, observational study of people with Type 2 diabetes initiating second-line glucose-lowering therapy.
20
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
Suzanne V. Arnold,Kamlesh Khunti,Fabrice Bonnet,Bernard Charbonnel,Hungta Chen,Javier Cid-Ruzafa,Andrew Cooper,Peter Fenici,Marília B. Gomes,Niklas Hammar,Linong Ji,Gabriela Luporini‐Saraiva,Jesús Medina,Antonio Nicolucci,Larisa Ramirez,Marina Vladimirovna Shestakova,Iichiro Shimomura,Filip Surmont,Fengming Tang,Jiten Vora,Hirotaka Watada,Mikhail Kosiborod +21 more
TL;DR: The DISCOVER study as discussed by the authors examined the global prevalence of heart failure and the incidence of HF over 3 years of follow-up in patients with Type 2 diabetes (T2D) [by presence and absence of co-existing coronary artery disease (CAD).
13